Ketorolac Tromethamine Ophthalmic Solution, 0.5%, 5 mL, Rx Only, Sterile, Manufactured by: Apotex Inc., Richmond Hill, Ontario, Canada, L4C 5H2, Manufactured for: Apotex Corp., Weston, FL 33326, NDC 60505-1003-1.
Published October 8, 2025 · Recall initiated: September 5, 2025
Summary
FDA records drug Class II recall D-0677-2025, published October 8, 2025 and initiated September 5, 2025. Recalling firm: Apotex Corp.; Status: Ongoing; Reported quantity: 493,468 bottles; Lot: Batch # VA0444, exp. date 01/2026 Batch # VA4608, exp. date 01/2026 Batch # TZ7016, exp. date 12/2025 UPC on Bottles: (01)0(03)60505100316 UPC on Cartons: 360505100316. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility; atypical weight loss due to improper bottle sealing leading to potential sterility concerns
What to do
Voluntary: Firm initiated · Letter
Get an email if KETOROLAC TROMETHAMINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- KETOROLAC TROMETHAMINE
- Manufacturer
- Apotex Corp.
- Distributor
- Nationwide in the US
- UPC
- 360505100316
- Lot
- Batch # VA0444, exp. date 01/2026 Batch # VA4608, exp. date 01/2026 Batch # TZ7016, exp. date 12/2025 UPC on Bottles: (01)0(03)60505100316 UPC on Cartons: 360505100316
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAKetorolac Tromethamine Injection, USP, 60 mg/2 mL (30 mg/mL), 2 mL Single-Dose Vial, For Intramuscular UseOctober 29, 2025
- FDABrimonidine Tartrate/Timolol Maleate Ophthalmic Solution, 0.2%/0.5%, a) 5 mL and b) 10 mL, Rx Only, Sterile,October 8, 2025
- FDAWhole Foods Market Blueberry Almond Granola, PLU 86032, packaged in a clear plastic container.October 8, 2025
- FDAKetorolac Tromethamine Ophthalmic Solution, 0.5%, 10 mL, Rx Only, Manufactured by: Apotex Inc., Toronto,July 2, 2025
- FDAKetorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL), packaged in 2 mL single dose vials, Rx Only,August 24, 2022
- FDAKetorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), packaged in 2 mL Single Dose Vial, RxJanuary 6, 2021
Questions about this recall
Was Ketorolac Tromethamine Ophthalmic Solution, 0.5%, 5 mL, Rx Only, Sterile, Manufactured by: Apotex Inc., Richmond Hill, Ontario, Canada, L4C 5H2, Manufactured for: Apotex Corp., Weston, FL 33326, NDC 60505-1003-1. recalled?
Yes. FDA published recall D-0677-2025 on October 8, 2025. Reported hazard: Lack of Assurance of Sterility; atypical weight loss due to improper bottle sealing leading to potential sterility concerns
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: KETOROLAC TROMETHAMINE. UPC: 360505100316.